Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis

被引：0
|
作者：
Toruner, M. [1 ]
Guvenir, T. [1 ]
Er, R. E. [1 ]
Soykan, I. [1 ]
机构：
[1] Ankara Univ, Dept Gastroenterol, Sch Med, Ankara, Turkiye
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P401
引用
收藏
页码：531 / 532
页数：2
相关论文
共 50 条
  • [41] Population pharmacokinetics of subcutaneous vedolizumab in Crohn's disease and Ulcerative Colitis
    Vreman, N.
    Anjie, S., I
    Gecse, K. B.
    Lowenberg, M.
    D'Haens, G. R. A. M.
    Mathot, R. A. A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1256 - I1257
  • [42] Treatment of severe flares in Crohn's disease and ulcerative colitis
    Stallmach, Andreas
    Stallhofer, Johannes
    Schmidt, Carsten
    Atreya, Raja
    Grunert, Philip C.
    INNERE MEDIZIN, 2025, 66 (01): : 22 - 30
  • [43] Review of vedolizumab for the treatment of ulcerative colitis
    Michelle SY Lau
    Her Hsin Tsai
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016, (01) : 107 - 111
  • [44] The safety of vedolizumab for the treatment of ulcerative colitis
    Novak, Gregor
    Hindryckx, Pieter
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 501 - 507
  • [45] Chronic inflammatory intestinal diseases:Crohn's disease and ulcerative colitis.: Part 2:: Imaging of ulcerative colitis,treatment of Crohn's disease and ulcerative colitis
    Feuerbach, S
    Scholmerich, J
    RADIOLOGE, 2000, 40 (04): : 415 - 428
  • [46] Early clinical experience with vedolizumab in the treatment of patients with Crohn's disease and ulcerative colitis: The Royal Adelaide Hospital experience
    De Koning, M.
    Andrews, J. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 138 - 138
  • [47] New Real World Analyzes demonstrate the Efficacy and Tolerability of Entyvio® (Vedolizumab) in the Treatment of Ulcerative colitis and Crohn's Disease
    不详
    VISCERAL MEDICINE, 2017, 33 (04) : 308 - 308
  • [48] Predictors of vedolizumab treatment persistence in bio-naive ulcerative colitis patients
    Ritter, T. E.
    Sarles, H. E.
    Mehta, S. A.
    Van Anglen, L. J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S523 - S524
  • [49] PREDICTORS OF VEDOLIZUMAB TREATMENT PERSISTENCE IN BIO-NAIVE ULCERATIVE COLITIS PATIENTS
    Ritter, Timothy E.
    Sarles, Harry E.
    Mehta, Samantha A.
    Van Anglen, Lucinda J.
    GASTROENTEROLOGY, 2020, 158 (06) : S962 - S962
  • [50] Population pharmacokinetic modelling of vedolizumab in patients with ulcerative colitis or Crohn's disease
    Rosario, M.
    Dirks, N.
    Gastonguay, M.
    Fox, I.
    Milton, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S225 - S226
12345